Tim Lu via TED Talks (TED Conferences)

Tim Lu takes Sen­ti and its gene cir­cuit tech pub­lic in $296M deal rid­ing on Omid Farokhzad's SPAC

Omid Farokhzad didn’t have to trav­el far to find a pri­vate biotech he want­ed to take pub­lic with his $200 mil­lion blank-check com­pa­ny.

Sen­ti Bio — the syn­thet­ic bi­ol­o­gy play launched and now helmed by MIT whiz Tim Lu — will be merg­ing with Farokhzad’s Dy­nam­ics Spe­cial Pur­pose Corp., the com­pa­nies an­nounced Mon­day morn­ing, in a deal set to de­liv­er $296 mil­lion in gross pro­ceeds.

Us­ing a gene cir­cuit tech­nol­o­gy plat­form out of Lu’s lab, Sen­ti promis­es to pro­gram “sense-com­pute-re­spond” ca­pa­bil­i­ties in­to cell and gene ther­a­pies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.